News About: Pharm. Industry
Lilly to expand partnership with Korean drug makers
Eli Lilly and Company a leading innovation-driven corporation, plans to create its ambitious partnership with Korean pharmaceutical companies for joint research and development (R&D) of new drugs and medical technolog...
Authorities to toughen stance on cGMP
The Ministry of Health and Welfare said it will toughen the current regulations of the Good Manufacturing Practice to require a variety of testing instruments.
The move comes after the ministry ordered tougher meas...
Ogilvy Healthworld announces acquisition of Pharmax
Ogilvy Healthworld, the healthcare communications arm of Ogilvy Worldwide, announced on August 21 that under regulatory approvals, it acquired 70% of Pharmax Research & Consulting, Inc. in Korea.
For most of the ma...
Research-based firms to get tax cuts and government fund
The government said on August 22 that it will provide tax benefits to research-oriented domestic companies as part of follow-up measures to the free trade agreement (FTA) signed with the United States, according to th...
LG Life Sciences sues domestic drug makers
LG Life Sciences said on August 23 that it is suing local pharmaceutical companies for violating its patent right of Zanidip (lercanidipine HCl), a calcium channel blocker.
Calcium channel blockers are widely used ...
Lylly's Actos outruns Avandia sales due to drug safety problems.
The sales of Actos, a rival anti-diabetic drug for type 2 diabetes developed and marketed by Lilly, showed far surpassing to Avandia by 24% increase in June over the previous month probably due to the recent serious r...
MSD's Gardasil soon to launch far ahead of GSK's Cervarix.
GSK and MSD may compete with the cervical cancer vaccine, called Cervarix and Gardasil.
However, MSD Korea already got the KFDA approval of Gardasil for the market launching in coming Sept, far ahead to GSK's Cerva...
Pharmaceutical industry slow in management during 1/2 of 2007.
During the first half of this year major pharmaceutical companies did not make any favorable business outcomes despite their struggling efforts.
39 listed drug companies sold the total 2,857,400 million won in fir...
TAP completes Phase II studies of ilaprazole
The U.S.-based TAP Pharmaceutical Products Inc. has completed a Phase II test for ilaprazole, a new investigational proton pump inhibitor (PPI) in the United States, said an official at Ilyang Pharm on August 22.
T...
SK sold 10 million units of prefilled syringe vaccines.
SK Chemical announced that the company sold more than 10 million units of "Prefilled Syringe type of vaccines" in total aggregation so far.
The Prefilled syringe type of vaccine is a vaccine preparation filled in t...
